Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer

Clinical trial NCT02135822 · UNKNOWN

Trial details

NCT number: NCT02135822
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer

Start date: 2014-05-01
Primary completion: 2015-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.